TBX4
protein-codingT-box transcription factor 4, the group of T-box transcription factors
Gene summary
This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is the human homolog of mouse Tbx4, which is closely linked to Tbx2 on mouse chromosome 11. Similarly this gene, like TBX2, maps to human chromosome 17. Expression studies in mouse and chicken show that Tbx4 is expressed in developing hindlimb, but not in forelimb buds, suggesting a role for this gene in regulating limb development and specification of limb identity. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~32.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: SD
Disease ID:MONDO:0011054
Submitter: PanelApp Australia
Inheritance Pattern: SD
Disease ID:MONDO:0007841
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0017148
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007841
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0007841
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011054
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011054
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0015924
Submitter: ClinGen
T-Box transcription factor 4 (TBX4) is a part of the T-box gene family which plays an important role in the development of hind limb and pelvis. TBX4 is also expressed in lung mesenchyme during early embryogenesis and regulates lung branching morphogenesis. Mutations in TBX4 were first identified in small patella syndrome (SPS), which is characterized by small or no kneecaps and weak pelvic bones. Genetic evidence: TBX4 was first associated with pulmonary arterial hypertension (PAH) through identification of a 3.75 Mb microdeletion of 17q22q23.2 in a patient with multiple congenital anomalies and PAH (PMID: 21271665). However, the deletion region included 15 known genes, and therefore this case could not be scored. Subsequent publications identified intragenic TBX4 mutations in PAH. Two patients with insertions in TBX4 gene causing a premature stop codon were scored from PMID: 23592887. These patients had SPS and PAH phenotypes. Three nonsense mutations were scored from PMID: 27587546, and the patients had idiopathic or familial forms of PAH. Two nonsense mutations (one de novo) and one deletion were scored from PMID: 29631995, and the patients either had familial or idiopathic forms of PAH. These variants yielded a total score of 12 for genetic evidence. Two more recent studies PMID: 29650961 and PMID: 31727138 add a further 7 and 8 frameshift/stop-gain mutations respectively which were not scored, but indicate very strong replication over time. Experimental evidence: Expression of TBX4 and functional consequence of variants in the gene are not yet widely studied in relevance to PAH. PMID: 22876201 demonstrated strong expression of TBX4 in developing lung and trachea. PMID: 33385213 reported that in vitro knockdown of TBX4 resulted in decreased p-Smad1/5. Two patient-derived lymphoblast lines (one with a frameshift deletion and other with complete deletion of TBX4) also had significantly lower levels of p-Smad1/5 when compared to control cells. Smad phosphorylation is a key mediator of bone morphogenetic signaling, and is known to be attenuated in PAH, especially in cells with a BMPR2 mutation. Therefore, this study was scored for biochemical function, since the effect of reduced TBX4 levels on Smad phosphorylation is similar to that caused by haploinsufficiency for BMPR2, the most common cause of heritable PAH. Overall, the experimental evidence from both the studies yielded a score of 1. The total score including both genetic and experimental evidence was 13 and since there is replication over time, the evidence was finally classified as DEFINITIVE.
Inheritance Pattern: AD
Disease ID:MONDO:0007841
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007841
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Genitourinary; Musculoskeletal; Neurologic; Pulmonary
Intervention: Cardiovascular; Pulmonary
Rationale: The condition can include pulmonary artery hypertension, and awareness may allow prompt diagnosis and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TBX4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001321120.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 40 | 3 | 48 | ||
| missense | 4 | 9 | 151 | 19 | 4 | 187 |
| nonsense | 11 | 13 | 6 | 30 | ||
| start loss | 1 | 1 | ||||
| frameshift | 11 | 22 | 9 | 42 | ||
| splice donor/acceptor (+/-2bp) | 4 | 7 | 1 | 12 | ||
| Total | 30 | 52 | 172 | 59 | 7 | 320 |
Highest pathogenic variant AF is 0.0000935529
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001308049.1 | 8 | MANE Select | |
| Ensembl | ENSP00000495986.1 | 8 | MANE Select | |
| RefSeq | NP_060958.2 | 8 | Standard | |
| Ensembl | ENSP00000240335.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tbx4 | Danio rerio | Structure: pelvic fin skeleton Quality: absent abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- angiogenesis
- morphogenesis of an epithelium
- regulation of transcription, DNA-templated
- regulation of transcription by RNA polymerase II
- multicellular organism development
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
Cellular Component
- nucleus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000240335
- Coding exons
- 8
- Length
- 32707
- Individuals with no LoFs
- 125731
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 17
- Defined
- 125748
- p
- 0.0000676
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.871 | 269 | 312 | 0.861 | 0.0000190 | 3537 |
| Missense (PolyPhen) | 95 | 134.4 | 0.70683 | 1579 | ||
| Synonymous | -0.687 | 145 | 135 | 1.08 | 0.00000914 | 1103 |
| Loss of Function | 3.55 | 5 | 23.6 | 0.211 | 0.00000147 | 249 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000070 | 0.000070 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the transcriptional regulation of genes required for mesoderm differentiation. Probably plays a role in limb pattern formation.;
- Disease
- DISEASE: Ischiocoxopodopatellar syndrome (ICPPS) [MIM:147891]: An autosomal dominant bone disease characterized by patellar aplasia or hypoplasia and by anomalies of the pelvis and feet, including disrupted ossification of the ischia and inferior pubic rami. {ECO:0000269|PubMed:15106123}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- LoFtool
- 0.109
- RVIS EVS
- -0.58
- RVIS percentile EVS
- 18.78
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.790
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | High | Medium | High |